Cuadro 2. Estadio anatómico/Grupos pronósticosa,b
| Revisión ISCL/EORTC para la estadificación de la micosis fungoide y síndrome de Sézary | ||||
| Estadio | T | N | M | Compromiso de sangre periférica |
| IA | 1 | 0 | 0 | 0, 1 |
| IB | 2 | 0 | 0 | 0, 1 |
| IIA | 1, 2 | 1, 2 | 0 | 0, 1 |
| IIB | 3 | 0–2 | 0 | 0, 1 |
| III | 4 | 0–2 | 0 | 0, 1 |
| IIIA | 4 | 0–2 | 0 | 0 |
| IIIB | 4 | 0–2 | 0 | 1 |
| IVA1 | 1–4 | 0–2 | 0 | 2 |
| IVA2 | 1–4 | 3 | 0 | 0–2 |
| IVB | 1–4 | 0–3 | 1 | 0–2 |
| EORTC = European Organization of Research and Treatment of Cancer; ISCL = International Society for Cutaneous Lymphomas. | ||||
| aReproducido con permiso del AJCC: Primary cutaneous lymphomas. En: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, p 613-5. | ||||
| bAdaptado de Olsen et al.[1] |
Bibliografía
- Olsen E, Vonderheid E, Pimpinelli N, et al.: Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110 (6): 1713-22, 2007. [PUBMED Abstract]
